We are monitoring the impact of COVID-19 on North America Aptamers Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1072
Share on
Share on

North America Aptamers Market Research Report - Segmented By Type, Application, End User, & Country (the United States, Canada & Rest of North America) - Industry Analysis on Size, Share, Trends, Forecast, Growth (2020 to 2025)

Pulished: February, 2020
ID: 1072
Pages: 145

North America Aptamers Market Size (2020 to 2025):

The size of the North America Aptamers Market was valued at USD 66.88 Million in 2020 and predicted to grow USD 143.52 Million by the end of 2025, growing at a CAGR of 16.50% between 2020 to 2025. 

The enormous opportunities offered by the market for the key players are drug discovery, biomarker discovery, and diagnostics segments. The launch of Macugen, the first aptamer drug and the first diagnostic test for testing mycotoxins in grains has recognized the potential of aptamers in diagnostics and therapeutics. So, the market for aptamers is expected to grow, backed by technological advancements with respect to selection processes and synthesis.

The North American market is driven by advancement in technology, availability of R&D investments in pharmaceutical and biotechnology industries, low cost, and high efficacy in binding to large molecules compared to antibodies. Ethical issues for some aptamers, Stringent regulations in the use of aptamers, slow in reaching the market place due to regulatory hurdles may hinder the growth of the market. Aptamers are oligonucleotides that bind to a target protein, lipid, or nucleic acid molecules with high specificity.

This research report segmented and sub-segmented the North American Aptamers Market into the following categories:

By Type:

  • Peptide aptamers
  • Nucleic Acid aptamers
    • DNA-Based Aptamers
    • RNA-Based Aptamers
    • XNA-Based Aptamers

By  Application:

  • Therapeutics Development
  • Diagnostics
  • Research and Development

By End User:

  • Pharmaceutical Companies
  • Bio-Pharmaceutical companies
  • Academic and Research Centres

By Country: 

  • The United States
  • Canada
  • Rest of North America

Some of the promising companies operating in the North America Aptamers Market are AM Biotechnologies, Aptagen, Aptamer Sciences Inc, Aptamer Solutions Ltd, Aptus Biotech S.L, Base Pair Biotechnologies Inc, NeoVentures Biotechnology Inc, SomaLogic Inc, TriLink BioTechnologies Inc, Vivonics, Inc

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Peptide Aptamers

                                5.1.2 Nucleic Acid Aptamers       

                                                5.1.2.1 DNA-Based Aptamers

                                                5.1.2.2 RNA-Based Aptamers

                                                5.1.2.3 XNA-Based Aptamers

                5.2 By Application                           

                                5.2.1 Therapeutics Development             

                                5.2.2 Diagnostics             

                                5.2.3 Research and Developments          

                5.3 By End Users                             

                                5.3.1 Pharmaceutical Companies             

                                5.3.2 Bio-Pharmaceutical Companies     

                                5.3.3 Academic and Research Centers    

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 United States            

                                6.3 Canada         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 AM Biotechnologies               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Aptagen                      

                8.3 Aptamer Sciences Inc.                            

                8.4 Aptamer Solutions Ltd                           

                8.5 Aptus Biotech S.L.                    

                8.6 Base Pair Biotechnologies Inc                             

                8.7 NeoVentures Biotechnology Inc.                       

                8.8 SomaLogic Inc                           

                8.9 TriLink BioTechnologies Inc                  

                8.10 Vivonics, Inc                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Aptamers Market, By Type, From 2020 to 2025 (USD Million)
  2. North America Peptide Aptamers Market, By Region, From 2020 to 2025 (USD Million)
  3. North America Nucleic Acid Aptamers Market, By Region, From 2020 to 2025 (USD Million)
  4. North America Aptamers Market, By Application, From 2020 to 2025 (USD Million)
  5. North America Therapeutics Development Market, By Region, From 2020 to 2025 (USD Million)
  6. North America Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  7. North America Research and Development Market, By Region, From 2020 to 2025 (USD Million)
  8. North America Aptamers Market, By End-users, From 2020 to 2025 (USD Million)
  9. North America Pharmaceutical Companies Market, By Region, From 2020 to 2025 (USD Million)
  10. North America Bio-Pharmaceutical Companies Market, By Region, From 2020 to 2025 (USD Million)
  11. North America Academic and Research centers Market, By Region, From 2020 to 2025 (USD Million)
  12. United States Aptamers Market, By Type, From 2020 to 2025 (USD Million)
  13. United States Aptamers Market, By Application, From 2020 to 2025 (USD Million)
  14. United States Aptamers Market, By End-users, From 2020 to 2025 (USD Million)
  15. Canada Aptamers Market, By Type, From 2020 to 2025 (USD Million)
  16. Canada Aptamers Market, By Application, From 2020 to 2025 (USD Million)
  17. Canada Aptamers Market, By End-users, From 2020 to 2025 (USD Million)
  18. North America Aptamers Market, By Nucleic Acid Aptamers, From 2020 to 2025 (USD Million)
  19. North America DNA Based Aptamers Market, By Region, From 2020 to 2025 (USD Million)
  20. North America RNA Based Aptamers Market, By Region, From 2020 to 2025 (USD Million)
  21. North America XNA Based Aptamers Market, By Region, From 2020 to 2025 (USD Million)
  22. United States Aptamers Market, By Nucleic Acid Aptamers, From 2020 to 2025 (USD Million)
  23. Canada Aptamers Market, By Nucleic Acid Aptamers, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample